OVID — OVID THERAPEUTICS INC

Ownership history in TLS Advisors LLC  ·  11 quarters on record

This page tracks every 13F SEC filing in which TLS Advisors LLC reported a position in OVID THERAPEUTICS INC (OVID). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
20.5% (2023 Q3)
Avg. % of fund
5.95%
First filed
2022 Q4
Last filed
2025 Q4
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 13,600 -5,258 -27.9% 0.98% $374K $1.63
2025 Q3 REDUCED 18,858 -662,109 -97.2% 0.08% $26K $1.30
2025 Q2 UNCHANGED 680,967 — 0% 0.70% $225K $0.33
2025 Q1 UNCHANGED 680,967 — 0% 0.48% $213K $0.31
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    OVID price (monthly, adj. close)

Other funds also holding OVID

As of 2025 Q4 — sorted by position size

Ally Bridge Group (NY) LLC 3Y 3.03% Saturn V Capital Management LP 3Y 0.75% Affinity Asset Advisors, LLC 3Y 0.66% ADAR1 Capital Management, LLC 0.51% Sio Capital Management, LLC 3Y 7Y 0.37% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.18% Velan Capital Investment Management LP 3Y 0.15% AWM Investment Company, Inc. 3Y 7Y 0.14% Stonepine Capital Management, LLC 3Y 7Y 0.12% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 0.11%
← Back to TLS Advisors LLC Holdings